Artemisia argyi polysaccharide ameliorates hyperglycemia through modulating gut microbiota and serum metabolism in type 2 diabetic mice
Journal of Functional Foods · 2024-11 · 122 · 106525
DOI: 10.1016/j.jff.2024.106525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Functional Foods, 2024-11. Verfasst von Qiaoying Song und 6 weiteren Autor:innen. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Anyang Institute of Technology.
Abstract (Originalsprache)
• Treated with ALP-1 could alleviate hyperglycemia and hyperlipidemia in diabetic mice. • ALP-1 treatment promoted the production of short-chain fatty acids. • ALP-1 interventions significantly improved the community richness and diversity of gut microbiota. • ALP-1 exerts hypoglycemic effect through regulating intestinal flora. In this manuscript, we investigated the hypoglycemic effect and mechanism of Artemisia argyi polysaccharide (ALP-1) on high-fat diet/streptozotocin-induced diabetes mice. After 4 weeks of oral administration of ALP-1, the HALP-1 diabetic mice group showed a 27.2 % reduction in liver index, a 10.3 % decrease in fasting blood glucose, and a 14.19 % decrease in glycated serum protein compared to the DM group. Additionally, improvements were observed in oxidative stress, inflammatory response, and serum insulin levels. Furthermore, the HALP-1 group exhibited enhanced glucose tolerance, liver glycogen level, and insulin sensitivity. Moreover, ALP-1 could increase the abundance of SCFAs, especially n-butyric acid in intestinal contents and faeces of diabetes mice. Intestinal flora results showed that ALP-1 treatment increased the abundance of genus Allobaculum in the cecum of diabetic mice. The results of fecal microbiota transplantation and antibiotics treatment confirmed that ALP-1 exerts hypoglycemic effect through regulating intestinal flora to a certain extent. The findings of our investigation indicate that ALP-1 has the potential of ameliorate hyperglycemia through modulating gut microbiota and serum metabolism.
Förderung
- Anyang Institute of Technology
Zitieren
APA
Song, Q., Wu, H., Weng, S., Wang, Y., Kong, L., Liu, Z., & Zhang, K. (2024). Artemisia argyi polysaccharide ameliorates hyperglycemia through modulating gut microbiota and serum metabolism in type 2 diabetic mice. Journal of Functional Foods, 122, 106525. https://doi.org/10.1016/j.jff.2024.106525
Vancouver
Song Q, Wu H, Weng S, Wang Y, Kong L, Liu Z, et al. Artemisia argyi polysaccharide ameliorates hyperglycemia through modulating gut microbiota and serum metabolism in type 2 diabetic mice. Journal of Functional Foods. 2024;122:106525. doi:10.1016/j.jff.2024.106525
BibTeX
@article{Song2024,
author = {Song, Qiaoying and Wu, Hankui and Weng, Shaoting and Wang, Yao and Kong, Lingqi and Liu, Ziqing and Zhang, Kunpeng},
title = {Artemisia argyi polysaccharide ameliorates hyperglycemia through modulating gut microbiota and serum metabolism in type 2 diabetic mice},
journal = {Journal of Functional Foods},
year = {2024},
volume = {122},
pages = {106525},
doi = {10.1016/j.jff.2024.106525}
}
EUVIMED